been a year,,bunch of investigations...news coming soon...!!?
About time for a "new" anniversary article..
It should come back to market to benifit the CKD patients. FDA made the right decision to approve the drug. Come back Omontys!!
To much discovery to just throw away. It's worth a lot more than 40 million moving forward.
its the periodic jump from $1 to $2...trade it now for more strategic shares
Sentiment: Strong Buy